Document is current
Any future updates will be listed below
-
Authors
Yikemu, Xirenijiang
Keremu, Ajimu
Zou, Changye
Wang, Yongqian
Bo, Wang
Zhao, Zhiqiang
Tu, Jian
Lin, Tiao
Yin, Junqiang
Shen, Jingnan
- License Information
-
More Information
Article History
Received: 2 March 2025
Accepted: 12 June 2025
First Online: 21 June 2025
Declarations
:
: This study was approved by the Medical Ethical Committee of The First Affiliated Hospital, Sun Yat-sen University, and followed the ethical standards of the Helsinki Declaration and national legislation.
: Informed consent (Consent to Participate and Consent to Publish) was obtained from all individual participants included in the study. For participants under the age of 18, consent was obtained from a parent or legal guardian.
: The authors declare no competing interests.
: Permission was obtained for any material reproduced from other sources where applicable.
: This study was not registered as a clinical trial. It is a retrospective therapeutic study involving 14 patients with phosphaturic mesenchymal tumors (PMT) who were treated and pathologically confirmed at our bone tumor center between December 2016 and September 2023.
: Permission to reproduce material from other sources was obtained where applicable.
